[Visual diagnosis while performing transurethral resection of bladder tumors: power or myth?]

Urologe A. 2014 Nov;53(11):1639-43. doi: 10.1007/s00120-014-3585-2.
[Article in German]

Abstract

Introduction: The gold standard for diagnosis and immediate therapy of bladder cancer is a transurethral resection (TURB) followed by histopathologic evaluation. The aim of this study was to assess the reliability of visual diagnosis by the operating urologist concerning dignity (malignant/benign) and staging compared to histopathologic evaluation. This is especially crucial since early mitomycin C instillation is based on the urologist's first impression.

Study design and methods: This prospective study included 311 cases of TURB from five German institutions. Surgeons were asked to estimate dignity of the neoplasm, tumor stage, and grade according to a standardized questionnaire.

Results: The subjective estimation/visual diagnosis of the operating urologist achieved a sensitivity with respect to identifying malignant tumors as such of 97%, while specificity was only 41%. Accordingly, the positive (PPV) and negative predictive values (NPV) were 76% and 88%, respectively. In general, muscle invasive cancer was predicted more often than confirmed by pathology (PPV 52%). However, whenever muscle invasive cancer was excluded by the urologist, this was confirmed by the pathologist in most the cases (NPV 95%). The educational degree did not influence the reliability and predictive value of visual diagnosis.

Conclusion: This study shows that urologists cannot reliably distinguish benign from malignant lesions of bladder mucosa-regardless of their educational degree. A reliable diagnosis of a pathologist is definitely needed to plan final therapeutic steps.

Publication types

  • Controlled Clinical Trial
  • English Abstract
  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Clinical Competence
  • Cystoscopy / methods*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Monitoring, Intraoperative / methods*
  • Observer Variation
  • Physical Examination / methods*
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Urethra*
  • Urinary Bladder Neoplasms / diagnosis*
  • Urinary Bladder Neoplasms / surgery*